Business and Economy / News 26.04.2023 PharmaMar Group reported total revenues of €34.0 million in 1Q2023, compared with €53.2 million in 1Q2022
News / Science and technologies 26.04.2023 ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE)